Cargando…

Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime

11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-)...

Descripción completa

Detalles Bibliográficos
Autores principales: Matveevskaya, Vladislava V., Pavlov, Dmitry I., Kovrizhina, Anastasia R., Sukhikh, Taisiya S., Sadykov, Evgeniy H., Dorovatovskii, Pavel V., Lazarenko, Vladimir A., Khlebnikov, Andrei I., Potapov, Andrei S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383563/
https://www.ncbi.nlm.nih.gov/pubmed/37513989
http://dx.doi.org/10.3390/pharmaceutics15071802
_version_ 1785080941233831936
author Matveevskaya, Vladislava V.
Pavlov, Dmitry I.
Kovrizhina, Anastasia R.
Sukhikh, Taisiya S.
Sadykov, Evgeniy H.
Dorovatovskii, Pavel V.
Lazarenko, Vladimir A.
Khlebnikov, Andrei I.
Potapov, Andrei S.
author_facet Matveevskaya, Vladislava V.
Pavlov, Dmitry I.
Kovrizhina, Anastasia R.
Sukhikh, Taisiya S.
Sadykov, Evgeniy H.
Dorovatovskii, Pavel V.
Lazarenko, Vladimir A.
Khlebnikov, Andrei I.
Potapov, Andrei S.
author_sort Matveevskaya, Vladislava V.
collection PubMed
description 11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-) in these compounds was so far unknown. In this contribution, we report the results of the determination of the double bond configuration in the solid state by single crystal X-ray diffraction and in solution by 1D and 2D NMR techniques and DFT calculations. It was found that both in the solid state and in solution, IQ-1 adopts the E-configuration stabilized by intermolecular hydrogen bonds, in contrast to previously assumed Z-configuration that could be stabilized only by an intramolecular hydrogen bond.
format Online
Article
Text
id pubmed-10383563
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103835632023-07-30 Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime Matveevskaya, Vladislava V. Pavlov, Dmitry I. Kovrizhina, Anastasia R. Sukhikh, Taisiya S. Sadykov, Evgeniy H. Dorovatovskii, Pavel V. Lazarenko, Vladimir A. Khlebnikov, Andrei I. Potapov, Andrei S. Pharmaceutics Article 11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-) in these compounds was so far unknown. In this contribution, we report the results of the determination of the double bond configuration in the solid state by single crystal X-ray diffraction and in solution by 1D and 2D NMR techniques and DFT calculations. It was found that both in the solid state and in solution, IQ-1 adopts the E-configuration stabilized by intermolecular hydrogen bonds, in contrast to previously assumed Z-configuration that could be stabilized only by an intramolecular hydrogen bond. MDPI 2023-06-23 /pmc/articles/PMC10383563/ /pubmed/37513989 http://dx.doi.org/10.3390/pharmaceutics15071802 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Matveevskaya, Vladislava V.
Pavlov, Dmitry I.
Kovrizhina, Anastasia R.
Sukhikh, Taisiya S.
Sadykov, Evgeniy H.
Dorovatovskii, Pavel V.
Lazarenko, Vladimir A.
Khlebnikov, Andrei I.
Potapov, Andrei S.
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
title Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
title_full Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
title_fullStr Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
title_full_unstemmed Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
title_short Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
title_sort experimental and computational investigation of the oxime bond stereochemistry in c-jun n-terminal kinase 3 inhibitors 11h-indeno[1,2-b]quinoxalin-11-one oxime and tryptanthrin-6-oxime
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383563/
https://www.ncbi.nlm.nih.gov/pubmed/37513989
http://dx.doi.org/10.3390/pharmaceutics15071802
work_keys_str_mv AT matveevskayavladislavav experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT pavlovdmitryi experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT kovrizhinaanastasiar experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT sukhikhtaisiyas experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT sadykovevgeniyh experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT dorovatovskiipavelv experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT lazarenkovladimira experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT khlebnikovandreii experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime
AT potapovandreis experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime